高级检索
当前位置: 首页 > 详情页

Star-shaped polymer of β-cyclodextrin-g-vitamin E TPGS for doxorubicin delivery and multidrug resistance inhibition

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE ◇ EI

单位: [1]Huazhong Univ Sci & Technol, Tongji Sch Pharm, Wuhan 430030, Hubei, Peoples R China [2]Natl Ctr Nanosci & Technol, CAS Excellent Ctr Nanosci, CAS Key Lab Biomed Effects Nanomat & Nanosafety, Beijing 100190, Peoples R China [3]Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Radiol, Wuhan 430030, Hubei, Peoples R China [4]Huazhong Univ Sci & Technol, Natl Engn Res Ctr Nanomed, Wuhan 430030, Hubei, Peoples R China [5]Huazhong Univ Sci & Technol, Hubei Engn Res Ctr Novel Drug Delivery Syst, Wuhan 430030, Hubei, Peoples R China
出处:
ISSN:

关键词: beta-Cyclodextrin d-alpha-Tocopheryl polyethylene glycol succinate Multidrug resistance Cancer Nanomedicine

摘要:
Multidrug resistance (MDR) remains as an obstacle for effective cancer treatment. Herein, we developed a novel and efficient nanomedicine by virtue of the carrier characters and MDR inhibition effects of beta-cyclodextrin (beta-CD) and d-alpha-tocopheryl polyethylene glycol succinate (TPGS). A series of star-shaped polymers CD-g-TPGS with different TPGS substitution degree were synthesized for doxorubicin (DOX) delivery, where beta-CD was identified as a core and TPGS as branches. These star polymers can self-assemble into nanoparticles with DOX. These nanoparticles showed no significant differences in size, zeta potential and morphology except for in vitro stability. They demonstrated good biocompatibility and enhanced cellular uptake in both drug sensitive and resistant cancer cells. Notably, the nanoparticles exhibited superiority of cytotoxicity in drug resistant cancer cells against free DOX. In vivo antitumor effect also demonstrated the improved cancer inhibition effect. This work suggests that star-shaped polymers CD-g-TPGS are promising drug carriers to overcome MDR in cancer treatment. (C) 2018 Elsevier B.V. All rights reserved.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2017]版:
大类 | 2 区 生物
小类 | 2 区 生物物理 2 区 材料科学:生物材料 3 区 物理化学
最新[2025]版:
大类 | 2 区 医学
小类 | 1 区 生物物理 3 区 材料科学:生物材料
JCR分区:
出版当年[2016]版:
Q1 BIOPHYSICS Q2 MATERIALS SCIENCE, BIOMATERIALS Q2 CHEMISTRY, PHYSICAL
最新[2023]版:
Q1 BIOPHYSICS Q2 CHEMISTRY, PHYSICAL Q2 MATERIALS SCIENCE, BIOMATERIALS

影响因子: 最新[2023版] 最新五年平均 出版当年[2016版] 出版当年五年平均 出版前一年[2015版] 出版后一年[2017版]

第一作者:
第一作者单位: [1]Huazhong Univ Sci & Technol, Tongji Sch Pharm, Wuhan 430030, Hubei, Peoples R China
通讯作者:
通讯机构: [1]Huazhong Univ Sci & Technol, Tongji Sch Pharm, Wuhan 430030, Hubei, Peoples R China [4]Huazhong Univ Sci & Technol, Natl Engn Res Ctr Nanomed, Wuhan 430030, Hubei, Peoples R China [5]Huazhong Univ Sci & Technol, Hubei Engn Res Ctr Novel Drug Delivery Syst, Wuhan 430030, Hubei, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:428 今日访问量:1 总访问量:411 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)